Industry: Service & Software
Published Date: 2026-04-21
Pages: 110 Pages
Report ld: 6570933
Request Sample
Customized Report
The global Oncology Automation market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Global health care expenditure currently accounts for approximately 10% of global GDP, and the proportion will continue to increase in the next few years. This is primarily due to the increasing demand for healthcare from an aging population, the rising prevalence of chronic and infectious diseases, and the expansion of emerging markets. The increasing global demand for advanced medical services, advancements in medical technology, growing elderly population, increasing medical expenditures, and increasing awareness of early disease diagnosis and treatment have become the main factors driving the market development, and the market development potential is huge.
This report delivers a comprehensive overview of the global Oncology Automation market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Oncology Automation. The Oncology Automation market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Oncology Automation market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Oncology Automation manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Oncology Automation companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Oncology Automation Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 AI
1.2.3 Robotic Process Automation (RPA)
1.2.4 Database Management System
1.2.5 EMR
1.2.6 Others
1.3 Market by Application
1.3.1 Global Oncology Automation Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Oncologists
1.3.3 Pharmacists
1.3.4 Technicians
1.3.5 Nurses
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Oncology Automation Market Perspective (2021–2032)
2.2 Global Oncology Automation Growth Trends by Region
2.2.1 Global Oncology Automation Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Oncology Automation Historic Market Size by Region (2021–2026)
2.2.3 Oncology Automation Forecasted Market Size by Region (2027–2032)
2.3 Oncology Automation Market Dynamics
2.3.1 Oncology Automation Industry Trends
2.3.2 Oncology Automation Market Drivers
2.3.3 Oncology Automation Market Challenges
2.3.4 Oncology Automation Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Oncology Automation Players by Revenue
3.1.1 Global Top Oncology Automation Players by Revenue (2021–2026)
3.1.2 Global Oncology Automation Revenue Market Share by Players (2021–2026)
3.2 Global Top Oncology Automation Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Oncology Automation Revenue
3.4 Global Oncology Automation Market Concentration Ratio
3.4.1 Global Oncology Automation Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Oncology Automation Revenue in 2025
3.5 Global Key Players of Oncology Automation Head Offices and Areas Served
3.6 Global Key Players of Oncology Automation, Products and Applications
3.7 Global Key Players of Oncology Automation, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Oncology Automation Breakdown Data by Type
4.1 Global Oncology Automation Historic Market Size by Type (2021–2026)
4.2 Global Oncology Automation Forecasted Market Size by Type (2027–2032)
5 Oncology Automation Breakdown Data by Application
5.1 Global Oncology Automation Historic Market Size by Application (2021–2026)
5.2 Global Oncology Automation Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Oncology Automation Market Size (2021–2032)
6.2 North America Oncology Automation Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Oncology Automation Market Size by Country (2021–2026)
6.4 North America Oncology Automation Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Oncology Automation Market Size (2021–2032)
7.2 Europe Oncology Automation Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Oncology Automation Market Size by Country (2021–2026)
7.4 Europe Oncology Automation Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Oncology Automation Market Size (2021–2032)
8.2 Asia-Pacific Oncology Automation Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Oncology Automation Market Size by Region (2021–2026)
8.4 Asia-Pacific Oncology Automation Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Oncology Automation Market Size (2021–2032)
9.2 Latin America Oncology Automation Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Oncology Automation Market Size by Country (2021–2026)
9.4 Latin America Oncology Automation Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Oncology Automation Market Size (2021–2032)
10.2 Middle East & Africa Oncology Automation Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Oncology Automation Market Size by Country (2021–2026)
10.4 Middle East & Africa Oncology Automation Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Radformation
11.1.1 Radformation Company Details
11.1.2 Radformation Business Overview
11.1.3 Radformation Oncology Automation Introduction
11.1.4 Radformation Revenue in Oncology Automation Business (2021–2026)
11.1.5 Radformation Recent Development
11.2 BD
11.2.1 BD Company Details
11.2.2 BD Business Overview
11.2.3 BD Oncology Automation Introduction
11.2.4 BD Revenue in Oncology Automation Business (2021–2026)
11.2.5 BD Recent Development
11.3 Oncology Consultants+Samacare
11.3.1 Oncology Consultants+Samacare Company Details
11.3.2 Oncology Consultants+Samacare Business Overview
11.3.3 Oncology Consultants+Samacare Oncology Automation Introduction
11.3.4 Oncology Consultants+Samacare Revenue in Oncology Automation Business (2021–2026)
11.3.5 Oncology Consultants+Samacare Recent Development
11.4 Mirada
11.4.1 Mirada Company Details
11.4.2 Mirada Business Overview
11.4.3 Mirada Oncology Automation Introduction
11.4.4 Mirada Revenue in Oncology Automation Business (2021–2026)
11.4.5 Mirada Recent Development
11.5 Datos Health
11.5.1 Datos Health Company Details
11.5.2 Datos Health Business Overview
11.5.3 Datos Health Oncology Automation Introduction
11.5.4 Datos Health Revenue in Oncology Automation Business (2021–2026)
11.5.5 Datos Health Recent Development
11.6 MIM Software Inc
11.6.1 MIM Software Inc Company Details
11.6.2 MIM Software Inc Business Overview
11.6.3 MIM Software Inc Oncology Automation Introduction
11.6.4 MIM Software Inc Revenue in Oncology Automation Business (2021–2026)
11.6.5 MIM Software Inc Recent Development
11.7 Elekta AB
11.7.1 Elekta AB Company Details
11.7.2 Elekta AB Business Overview
11.7.3 Elekta AB Oncology Automation Introduction
11.7.4 Elekta AB Revenue in Oncology Automation Business (2021–2026)
11.7.5 Elekta AB Recent Development
11.8 Varian Medical Systems/Siemens
11.8.1 Varian Medical Systems/Siemens Company Details
11.8.2 Varian Medical Systems/Siemens Business Overview
11.8.3 Varian Medical Systems/Siemens Oncology Automation Introduction
11.8.4 Varian Medical Systems/Siemens Revenue in Oncology Automation Business (2021–2026)
11.8.5 Varian Medical Systems/Siemens Recent Development
11.9 Philips
11.9.1 Philips Company Details
11.9.2 Philips Business Overview
11.9.3 Philips Oncology Automation Introduction
11.9.4 Philips Revenue in Oncology Automation Business (2021–2026)
11.9.5 Philips Recent Development
11.10 MedLever Inc
11.10.1 MedLever Inc Company Details
11.10.2 MedLever Inc Business Overview
11.10.3 MedLever Inc Oncology Automation Introduction
11.10.4 MedLever Inc Revenue in Oncology Automation Business (2021–2026)
11.10.5 MedLever Inc Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global market for Oncology Automation was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-07-14
Pages: 110
USD 3950.00
(Single User License)
The global Oncology Automation market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-10-23
Pages: 125
USD 4900.00
(Single User License)
The global market for Oncology Automation was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-20
Pages: 98
USD 3950.00
(Single User License)
The global market for Oncology Automation was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-02-20
Pages: 76
USD 2900.00
(Single User License)
Market Analysis and Insights: Global Oncology Automation Market
Published Date: 2024-04-11
Pages: 109
USD 4900.00
(Single User License)
The global Oncology Automation market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published Date: 2024-01-12
Pages: 87
USD 2900.00
(Single User License)
The global market for Oncology Automation was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
Published Date: 2024-01-06
Pages: 117
USD 3950.00
(Single User License)
The global market for Oncology Automation was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-07-14
Pages: 110
The global Oncology Automation market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-10-23
Pages: 125
The global market for Oncology Automation was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-20
Pages: 98
The global market for Oncology Automation was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-02-20
Pages: 76
Market Analysis and Insights: Global Oncology Automation Market
Published: 2024-04-11
Pages: 109
The global Oncology Automation market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published: 2024-01-12
Pages: 87
The global market for Oncology Automation was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
Published: 2024-01-06
Pages: 117
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now